Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
39.84
+1.49 (3.89%)
At close: Dec 20, 2024, 4:00 PM
40.34
+0.50 (1.25%)
After-hours: Dec 20, 2024, 6:36 PM EST
Aligos Therapeutics Market Cap
Aligos Therapeutics has a market cap or net worth of $147.87 million as of December 20, 2024. Its market cap has increased by 203.60% in one year.
Market Cap
147.87M
Enterprise Value
82.08M
1-Year Change
203.60%
Ranking
Category
Stock Price
$39.84
Market Cap Chart
Since the IPO on October 16, 2020, Aligos Therapeutics's market cap has decreased from $553.35M to $147.87M, a decrease of -73.28%. That is a compound annual growth rate of -27.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 147.87M | 197.20% |
| Dec 29, 2023 | 49.75M | 21.95% |
| Dec 30, 2022 | 40.80M | -91.93% |
| Dec 31, 2021 | 505.85M | -52.00% |
| Dec 31, 2020 | 1.05B | 90.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| The Joint | 153.88M |
| Telomir Pharmaceuticals | 153.38M |
| Biomea Fusion | 153.29M |
| Metagenomi | 151.57M |
| Zura Bio | 148.87M |
| Nevro | 142.02M |
| Vaxart | 140.95M |
| Compugen | 136.99M |